Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Contraceptive Effect" patented technology

Common side effects of oral contraceptives include: Hormonal contraception is taken to prevent pregnancy and for other medical reasons. intermenstrual spotting. nausea. breast tenderness. headaches and migraine. weight gain. mood changes.

Chewable oral contraceptive

PendingUS20250186337A1Organic active ingredientsPill deliveryDrospirenoneOral contraceptive drug
Owner:CHEMO RES SL

Bromodomain and extra-terminal (BET) subfamily bromodomain 1 (BD1) selective inhibitors and methods using same

The present disclosure relates to compounds which inhibit bromodomain testis (BRDT). In certain embodiments, the compound is a bromodomain and extra-terminal (BET) subfamily bromodomain 1 (BD1) selective compound. In certain embodiments, the compound selectively inhibits BD-1 over bromodomain 2 (BD2). The present disclosure further provides a method of inhibiting BRDT in a male subject, the method comprising administering to the male subject a therapeutically effective amount of a compound of the disclosure, whereby the male subject is provided a contraceptive effect. The present disclosure further provides a method of inhibiting BRD2, BRD3, BRD4, and / or BRDT in a subject with a cancer, inflammatory condition, infectious disease, and / or metabolic disorder in which one or more of BET proteins are regulators, the method comprising administering to the subject a therapeutically effective amount of a compound of the disclosure, thereby treating, preventing, and / or ameliorating the condition, disease, and / or disorder.
Owner:BAYLOR COLLEGE OF MEDICINE

Novel contraceptive device

PCT designated stageWO2026045724A1Male contraceptivesContraceptive EffectMechanical engineering
The present invention relates to the field of family planning supplies and particularly to a novel contraceptive device, comprising an insertion tube, a protective cover, a liquid collection bag, a ring, and a connecting thread. The protective cover is arranged at the top end of the insertion tube. The liquid collection bag is in communication with the insertion tube. The protective cover is arranged between the liquid collection bag and the insertion tube. The ring is connected to the protective cover by means of the connecting thread. The insertion tube, the protective cover, and the ring are all flexible. The liquid collection bag is contractable. The connecting thread is retractable. The present invention has a reasonable structure, is convenient to wear, safe, and sanitary, and produces a good contraceptive effect. The protective cover and the ring are connected by means of the connecting thread instead of adopting the full-coverage design of existing common condoms, thereby greatly increasing the contact area and improving the experience.
Owner:PENG ANHUA

Integrated geneman-mouller structure capable of releasing drug

The utility model relates to the field of gynecological appliances, in particular to a comprehensive Genimann-Luolele structure capable of releasing medicine by using a copper ring. The upper part of the fixing line can be nailed and hung in the uterine cavity; a plurality of copper rings are arranged on the fixing line in a penetrating manner, an upper bracket is arranged above a copper ring body, and a lower bracket is arranged below the copper ring body; the fixing line penetrates through the penetrating holes in the upper support and the lower support. The lower support can support medicine arranged in the copper ring, and the medicine is levonorgestrel. After the Munule and the Gini ring are combined into one and refitted, the Munule is fixed in the uterine superficial muscle layer through the Gini knot, the problems that the Munule moves downwards and falls off are perfectly solved, the treatment effect is achieved, and meanwhile the efficient and long-acting contraception effect is achieved for women with contraception requirements.
Owner:LIANYUNGANG MATERNAL & CHILD HEALTH HOSPITAL (LIANYUNGANG THIRD PEOPLES HOSPITAL)

Intrauterine contraceptive and monitoring system

UndeterminedES3073226T3PregnancyIntrauterine device
An intrauterine monitoring system is described. The system consists of an intrauterine device, designed and sized for implantation in the uterus, and a receiver. The intrauterine device measures the conditions within the uterus to generate sensor data and acts as a contraceptive method to prevent pregnancy. The receiver wirelessly receives the data generated by the intrauterine device.